InvestorsHub Logo
icon url

PennyWorld

03/11/22 4:47 PM

#43919 RE: JTORENCE #43918

JT..haven't you read the letter from Senator Johnson to the FDA and Fauci. Here is a repost.......

The Republicans are requesting answers to the following questions to better understand the FDA’s decisions regarding an EUA for ZYESAMI:

1. Please provide a timeline of FDA and NIAID actions to review ZYESAMI as an
emergency treatment for COVID-19.
2. Please provide documentation of any communications between FDA or NIAID and
physicians or hospitals that are utilizing ZYESAMI under Right to Try.
3. Has the FDA ever accepted the data of ongoing clinical trials when issuing an EUA for a
treatment for COVID-19? If so, please provide the treatment and its EUA.
4. Please explain why the FDA refuses to review ZYESAMI data until completion of a
clinical trial.
5. For COVID patients that received remdesivir and steroids but did not recover, what is the
FDA and NIAID’s current treatment recommendation?

They have asked for a response from the FDA and NIAID no later than 5:00 p.m. on March 17.
[color=red][/color]
Full article...
https://amgreatness.com/2022/03/09/in-letter-to-fda-and-niaid-ron-johnson-demands-to-know-why-promising-late-stage-covid-drug-was-never-approved/
icon url

changes_iv

03/11/22 6:18 PM

#43922 RE: JTORENCE #43918

Truth is unfolding.....Please see below statement from todays NRX 8-K filing.

"In light of the Company’s strategic focus and the ongoing hostilities in Eastern Europe, and following recent changes in the Ministry of Health in the nation of Georgia, the Company at this time will not be pursuing opportunities in Georgia (which neighbors Russia and Ukraine), elsewhere in the Caucasus region or Europe. In addition, the Board has determined that it could not confirm the current status or effectiveness of the authorization for emergency use of the Company’s COVID-19 therapeutic drug ZYESAMI® in Georgia. Although the Company engaged in an initial training of physicians, to date, the Company has not sold any doses of ZYESAMI® in Georgia. At this time, the Company has ceased efforts to pursue further regulatory drug interactions in Georgia or to conduct clinical trials there."

~ Posted by Newbie, Y@h00 RLFTF finance conversations

https://ir.nrxpharma.com/sec-filings/all-sec-filings/content/0000950142-22-000983/0000950142-22-000983.pdf

JJ and NRXP got a license from SUNY and somehow found out a huge benefactor in the NIH. They definitely own that mess! Reminds me of the socialist/Marxist democrat and his shovel-ready projects. Know a jackasset, know them all!